{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:38:05Z","timestamp":1792395485288,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>AAV-delivered CRISPR\/Cas9 (AAV-CRISPR) has shown promising potentials in preclinical models to efficiently insert therapeutic gene sequences in somatic tissues. However, the AAV input doses required were prohibitively high and posed serious risk of toxicity. Here, we performed AAV-CRISPR mediated homology-independent knock-in at a new target site in <jats:italic>mAlb<\/jats:italic> 3\u2019UTR and demonstrated that single dose of AAVs enabled long-term integration and expression of <jats:italic>hF9<\/jats:italic> transgene in both adult and neonatal hemophilia B mice (<jats:italic>mF9 \u2212\/\u2212)<\/jats:italic>, yielding high levels of circulating human Factor IX (hFIX) and stable hemostasis restoration during entire 48-week observation period. Furthermore, we achieved hemostasis correction with a significantly lower AAV dose (2 \u00d7 10<jats:sup>9<\/jats:sup> vg\/neonate and 1 \u00d7 10<jats:sup>10<\/jats:sup> vg\/adult mouse) through liver-specific gene knock-in using hyperactive <jats:italic>hF9<\/jats:italic><jats:sup><jats:italic>R338L<\/jats:italic><\/jats:sup> variant. The plasma antibodies against Cas9 and AAV in the neonatal mice receiving low-dose AAV-CRISPR were negligible, which lent support to the development of AAV-CRISPR mediated somatic knock-in for treating inherited diseases.<\/jats:p>","DOI":"10.1038\/s41467-022-34898-y","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T21:32:27Z","timestamp":1669411947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiangjun","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5554-8661","authenticated-orcid":false,"given":"Yaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Anugerah","family":"Urip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Christopher","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8160-6415","authenticated-orcid":false,"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-014X","authenticated-orcid":false,"given":"Duanqing","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2810-5758","authenticated-orcid":false,"given":"Chi-Kong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-3257","authenticated-orcid":false,"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"34898_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"34898_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nbt.3055","volume":"33","author":"L Swiech","year":"2015","unstructured":"Swiech, L. et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 33, 102\u2013106 (2015).","journal-title":"Nat. Biotechnol."},{"key":"34898_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"34898_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DB Cox","year":"2015","unstructured":"Cox, D. B., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121\u2013131 (2015).","journal-title":"Nat. Med."},{"key":"34898_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrd.2016.238","volume":"16","author":"C Fellmann","year":"2017","unstructured":"Fellmann, C., Gowen, B. G., Lin, P. C., Doudna, J. A. & Corn, J. E. Cornerstones of CRISPR-Cas in drug discovery and therapy. Nat. Rev. Drug Discov. 16, 89\u2013100 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"34898_CR6","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/jth.12958","volume":"13","author":"AC Goodeve","year":"2015","unstructured":"Goodeve, A. C. Hemophilia B: molecular pathogenesis and mutation analysis. J. Thromb. Haemost. 13, 1184\u20131195 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"34898_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature10177","volume":"475","author":"H Li","year":"2011","unstructured":"Li, H. et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217\u2013221 (2011).","journal-title":"Nature"},{"key":"34898_CR8","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","volume":"122","author":"XM Anguela","year":"2013","unstructured":"Anguela, X. M. et al. Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122, 3283\u20133287 (2013).","journal-title":"Blood"},{"key":"34898_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04625-5","volume":"7","author":"T Ohmori","year":"2017","unstructured":"Ohmori, T. et al. CRISPR\/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice. Sci. Rep. 7, 4159 (2017).","journal-title":"Sci. Rep."},{"key":"34898_CR10","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood.2019000790","volume":"133","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. CRISPR\/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX-knockout mice. Blood 133, 2745\u20132752 (2019).","journal-title":"Blood"},{"key":"34898_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1101\/gr.161638.113","volume":"24","author":"TO Auer","year":"2014","unstructured":"Auer, T. O., Duroure, K., De Cian, A., Concordet, J. P. & Del Bene, F. Highly efficient CRISPR\/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res. 24, 142\u2013153 (2014).","journal-title":"Genome Res."},{"key":"34898_CR12","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/nar\/gkw064","volume":"44","author":"X He","year":"2016","unstructured":"He, X. et al. Knock-in of large reporter genes in human cells via CRISPR\/Cas9-induced homology-dependent and independent DNA repair. Nucleic Acids Res. 44, e85 (2016).","journal-title":"Nucleic Acids Res."},{"key":"34898_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K. et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature 540, 144\u2013149 (2016).","journal-title":"Nature"},{"key":"34898_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53198-y","volume":"9","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII. Sci. Rep. 9, 16838 (2019).","journal-title":"Sci. Rep."},{"key":"34898_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1907-9","volume":"20","author":"JP Zhang","year":"2019","unstructured":"Zhang, J. P. et al. Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse. Genome Biol. 20, 276 (2019).","journal-title":"Genome Biol."},{"key":"34898_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","volume":"181","author":"D Wang","year":"2020","unstructured":"Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136\u2013150 (2020).","journal-title":"Cell"},{"key":"34898_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00109-020-02034-2","volume":"99","author":"X He","year":"2021","unstructured":"He, X., Urip, B. A., Zhang, Z., Ngan, C. C. & Feng, B. Evolving AAV-delivered therapeutics towards ultimate cures. J. Mol. Med 99, 593\u2013617 (2021).","journal-title":"J. Mol. Med"},{"key":"34898_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty, D. M., Monahan, P. E. & Samulski, R. J. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248\u20131254 (2001).","journal-title":"Gene Ther."},{"key":"34898_CR19","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","volume":"90","author":"HF Lin","year":"1997","unstructured":"Lin, H. F., Maeda, N., Smithies, O., Straight, D. L. & Stafford, D. W. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90, 3962\u20133966 (1997).","journal-title":"Blood"},{"key":"34898_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/mt.2008.72","volume":"16","author":"SC Cunningham","year":"2008","unstructured":"Cunningham, S. C., Dane, A. P., Spinoulas, A., Logan, G. J. & Alexander, I. E. Gene delivery to the juvenile mouse liver using AAV2\/8 vectors. Mol. Ther. 16, 1081\u20131088 (2008).","journal-title":"Mol. Ther."},{"key":"34898_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.omtm.2019.08.015","volume":"15","author":"S Pipe","year":"2019","unstructured":"Pipe, S., Leebeek, F. W. G., Ferreira, V., Sawyer, E. K. & Pasi, J. Clinical considerations for capsid choice in the development of liver-targeted AAV-Based gene transfer. Mol. Ther. Methods Clin. Dev. 15, 170\u2013178 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"34898_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z Wang","year":"2005","unstructured":"Wang, Z. et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321\u2013328 (2005).","journal-title":"Nat. Biotechnol."},{"key":"34898_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-018-0479-1","volume":"18","author":"S Rajasekaran","year":"2018","unstructured":"Rajasekaran, S. et al. Infectivity of adeno-associated virus serotypes in mouse testis. BMC Biotechnol. 18, 70 (2018).","journal-title":"BMC Biotechnol."},{"key":"34898_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ymthe.2017.12.007","volume":"26","author":"T VandenDriessche","year":"2018","unstructured":"VandenDriessche, T. & Chuah, M. K. Hyperactive factor IX padua: a game-changer for hemophilia gene therapy. Mol. Ther. 26, 14\u201316 (2018).","journal-title":"Mol. Ther."},{"key":"34898_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","volume":"10","author":"VL Simhadri","year":"2018","unstructured":"Simhadri, V. L. et al. Prevalence of pre-existing antibodies to CRISPR-associated nuclease Cas9 in the USA population. Mol. Ther. Methods Clin. Dev. 10, 105\u2013112 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"34898_CR26","doi-asserted-by":"crossref","unstructured":"De Caneva, A. et al. Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases. JCI Insight 5, e128863 (2019).","DOI":"10.1172\/jci.insight.128863"},{"key":"34898_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.omtm.2020.06.025","volume":"18","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. CRISPR-Cas9-mediated in vivo gene integration at the albumin locus recovers hemostasis in neonatal and adult hemophilia B mice. Mol. Ther. Methods Clin. Dev. 18, 520\u2013531 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"34898_CR28","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.jhepr.2019.100065","volume":"2","author":"SL Ginn","year":"2020","unstructured":"Ginn, S. L. et al. Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes. JHEP Rep. 2, 100065 (2020).","journal-title":"JHEP Rep."},{"key":"34898_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/ng1380","volume":"36","author":"DG Miller","year":"2004","unstructured":"Miller, D. G., Petek, L. M. & Russell, D. W. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet. 36, 767\u2013773 (2004).","journal-title":"Nat. Genet."},{"key":"34898_CR30","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","volume":"126","author":"R Sharma","year":"2015","unstructured":"Sharma, R. et al. In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126, 1777\u20131784 (2015).","journal-title":"Blood"},{"key":"34898_CR31","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. Long-term correction of haemophilia B through CRISPR\/Cas9 induced homology-independent targeted integration. J. Genet. Genomics 6, (2022). https:\/\/doi.org\/10.1016\/j.jgg.2022.06.001. Online ahead of print.","DOI":"10.1016\/j.jgg.2022.06.001"},{"key":"34898_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/mt.2016.35","volume":"24","author":"DJ Landau","year":"2016","unstructured":"Landau, D. J. et al. In vivo zinc finger nuclease-mediated targeted integration of a glucose-6-phosphatase transgene promotes survival in mice with glycogen storage disease type IA. Mol. Ther. 24, 697\u2013706 (2016).","journal-title":"Mol. Ther."},{"key":"34898_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer, C. et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum. Gene Ther. 29, 285\u2013298 (2018).","journal-title":"Hum. Gene Ther."},{"key":"34898_CR34","doi-asserted-by":"crossref","unstructured":"High-dose AAV gene therapy deaths. Nat. Biotechnol. 38, 910 (2020).","DOI":"10.1038\/s41587-020-0642-9"},{"key":"34898_CR35","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","volume":"19","author":"A Srivastava","year":"2013","unstructured":"Srivastava, A. et al. Guidelines for the management of hemophilia. Haemophilia 19, e1\u2013e47 (2013).","journal-title":"Haemophilia"},{"key":"34898_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/ctm2.34","volume":"10","author":"N Zheng","year":"2020","unstructured":"Zheng, N., Li, L. & Wang, X. Molecular mechanisms, off-target activities, and clinical potentials of genome editing systems. Clin. Transl. Med. 10, 412\u2013426 (2020).","journal-title":"Clin. Transl. Med."},{"key":"34898_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/nat.2019.0790","volume":"29","author":"CA Vakulskas","year":"2019","unstructured":"Vakulskas, C. A. & Behlke, M. A. Evaluation and reduction of CRISPR off-target cleavage events. Nucleic Acid Ther. 29, 167\u2013174 (2019).","journal-title":"Nucleic Acid Ther."},{"key":"34898_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.csbj.2019.11.006","volume":"18","author":"G Liu","year":"2020","unstructured":"Liu, G., Zhang, Y. & Zhang, T. Computational approaches for effective CRISPR guide RNA design and evaluation. Comput. Struct. Biotechnol. J. 18, 35\u201344 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"34898_CR39","doi-asserted-by":"publisher","first-page":"1902312","DOI":"10.1002\/advs.201902312","volume":"7","author":"H Manghwar","year":"2020","unstructured":"Manghwar, H. et al. CRISPR\/Cas systems in genome editing: methodologies and tools for sgRNA design, off-target evaluation, and strategies to mitigate off-target effects. Adv. Sci. 7, 1902312 (2020).","journal-title":"Adv. Sci."},{"key":"34898_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E. et al. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med. 25, 427\u2013432 (2019).","journal-title":"Nat. Med."},{"key":"34898_CR41","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nm.3230","volume":"19","author":"C Kaeppel","year":"2013","unstructured":"Kaeppel, C. et al. A largely random AAV integration profile after LPLD gene therapy. Nat. Med. 19, 889\u2013891 (2013).","journal-title":"Nat. Med."},{"key":"34898_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3343\/alm.2016.36.5.469","volume":"36","author":"KJ Park","year":"2016","unstructured":"Park, K. J. et al. Adeno-associated virus 2-mediated hepatocellular carcinoma is very rare in Korean patients. Ann. Lab. Med. 36, 469\u2013474 (2016).","journal-title":"Ann. Lab. Med."},{"key":"34898_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1089\/hum.2015.29014.kib","volume":"26","author":"KI Berns","year":"2015","unstructured":"Berns, K. I. et al. Adeno-associated virus type 2 and hepatocellular carcinoma? Hum. Gene Ther. 26, 779\u2013781 (2015).","journal-title":"Hum. Gene Ther."},{"key":"34898_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12449-2","volume":"10","author":"KS Hanlon","year":"2019","unstructured":"Hanlon, K. S. et al. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat. Commun. 10, 4439 (2019).","journal-title":"Nat. Commun."},{"key":"34898_CR45","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/s41467-021-26518-y","volume":"12","author":"R Ibraheim","year":"2021","unstructured":"Ibraheim, R. et al. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo. Nat. Commun. 12, 6267\u20136267 (2021).","journal-title":"Nat. Commun."},{"key":"34898_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-018-0616-2","volume":"16","author":"C Zhang","year":"2018","unstructured":"Zhang, C. et al. Homology-independent multiallelic disruption via CRISPR\/Cas9-based knock-in yields distinct functional outcomes in human cells. BMC Biol. 16, 151 (2018).","journal-title":"BMC Biol."},{"key":"34898_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med."},{"key":"34898_CR48","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","volume":"28","author":"A Li","year":"2020","unstructured":"Li, A. et al. AAV-CRISPR gene editing is negated by pre-existing immunity to Cas9. Mol. Ther. 28, 1432\u20131441 (2020).","journal-title":"Mol. Ther."},{"key":"34898_CR49","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ymthe.2020.05.007","volume":"28","author":"V Gough","year":"2020","unstructured":"Gough, V. & Gersbach, C. A. Immunity to Cas9 as an obstacle to persistent genome editing. Mol. Ther. 28, 1389\u20131391 (2020).","journal-title":"Mol. Ther."},{"key":"34898_CR50","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41551-019-0431-2","volume":"3","author":"AM Moreno","year":"2019","unstructured":"Moreno, A. M. et al. Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy. Nat. Biomed. Eng. 3, 806\u2013816 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"34898_CR51","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"34898_CR52","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1089\/hum.2010.055","volume":"21","author":"M Lock","year":"2010","unstructured":"Lock, M. et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum. Gene Ther. 21, 1259\u20131271 (2010).","journal-title":"Hum. Gene Ther."},{"key":"34898_CR53","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nprot.2008.80","volume":"3","author":"C Mitchell","year":"2008","unstructured":"Mitchell, C. & Willenbring, H. A reproducible and well-tolerated method for 2\/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167\u20131170 (2008).","journal-title":"Nat. Protoc."},{"key":"34898_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/crispr.2021.0113","volume":"5","author":"D Conant","year":"2022","unstructured":"Conant, D. et al. Inference of CRISPR edits from Sanger trace data. CRISPR J. 5, 123\u2013130 (2022).","journal-title":"CRISPR J."},{"key":"34898_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 12, 323 (2011).","journal-title":"BMC Bioinforma."},{"key":"34898_CR56","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"34898_CR57","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","volume":"38","author":"GH Putri","year":"2022","unstructured":"Putri, G. H., Anders, S., Pyl, P. T., Pimanda, J. E. & Zanini, F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics 38, 2943\u20132945 (2022).","journal-title":"Bioinformatics"},{"key":"34898_CR58","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34898-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T23:59:57Z","timestamp":1669420797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34898-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34898"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34898-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7275"}}